Your browser doesn't support javascript.
loading
Extracellular vesicles derived from Plasmodium-infected and non-infected red blood cells as targeted drug delivery vehicles.
Borgheti-Cardoso, Livia Neves; Kooijmans, Sander A A; Chamorro, Lucía Gutiérrez; Biosca, Arnau; Lantero, Elena; Ramírez, Miriam; Avalos-Padilla, Yunuen; Crespo, Isabel; Fernández, Irene; Fernandez-Becerra, Carmen; Del Portillo, Hernando A; Fernàndez-Busquets, Xavier.
Affiliation
  • Borgheti-Cardoso LN; Nanomalaria Group, Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain; Barcelona Institute for Global Health (ISGlobal, Hospital Clínic-Universitat de Barcelona), Barcelona, Spain. Electronic address: lborgheti@ibecbarcelona.e
  • Kooijmans SAA; CDL Research, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Chamorro LG; Nanomalaria Group, Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain; Barcelona Institute for Global Health (ISGlobal, Hospital Clínic-Universitat de Barcelona), Barcelona, Spain.
  • Biosca A; Nanomalaria Group, Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain; Barcelona Institute for Global Health (ISGlobal, Hospital Clínic-Universitat de Barcelona), Barcelona, Spain.
  • Lantero E; Nanomalaria Group, Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain; Barcelona Institute for Global Health (ISGlobal, Hospital Clínic-Universitat de Barcelona), Barcelona, Spain.
  • Ramírez M; Barcelona Institute for Global Health (ISGlobal, Hospital Clínic-Universitat de Barcelona), Barcelona, Spain.
  • Avalos-Padilla Y; Nanomalaria Group, Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain; Barcelona Institute for Global Health (ISGlobal, Hospital Clínic-Universitat de Barcelona), Barcelona, Spain.
  • Crespo I; Plataforma de Citometria, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Fernández I; Unitat d'Espectrometria de Masses de Caracterització Molecular, CCiTUB, Universitat de Barcelona (UB), Barcelona, Spain.
  • Fernandez-Becerra C; Barcelona Institute for Global Health (ISGlobal, Hospital Clínic-Universitat de Barcelona), Barcelona, Spain; Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol (IGTP), Badalona, Spain.
  • Del Portillo HA; Barcelona Institute for Global Health (ISGlobal, Hospital Clínic-Universitat de Barcelona), Barcelona, Spain; Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol (IGTP), Badalona, Spain; Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain.
  • Fernàndez-Busquets X; Nanomalaria Group, Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain; Barcelona Institute for Global Health (ISGlobal, Hospital Clínic-Universitat de Barcelona), Barcelona, Spain; Nanoscience and Nanotechnology Institute (IN2
Int J Pharm ; 587: 119627, 2020 Sep 25.
Article in En | MEDLINE | ID: mdl-32653596
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Plasmodium / Extracellular Vesicles Type of study: Qualitative_research Limits: Humans Language: En Journal: Int J Pharm Year: 2020 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Plasmodium / Extracellular Vesicles Type of study: Qualitative_research Limits: Humans Language: En Journal: Int J Pharm Year: 2020 Type: Article